Engineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes
By adding thrombomodulin (TM) and CD47 to the surface of islets, the researchers created a localized immune-modulating barrier that allowed transplanted cells t...
By adding thrombomodulin (TM) and CD47 to the surface of islets, the researchers created a localized immune-modulating barrier that allowed transplanted cells to survive and function. The post Engineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes appeared first on Inside Precision Medicine .